Market Place
Sourcing Support
SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial
24 Jan 2024 //
GLOBENEWSWIRE
SparingVision Reports +ve Initial Safety Data from the first cohort Ph I/II
30 Aug 2023 //
GLOBENEWSWIRE
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics
12 Jul 2023 //
GLOBENEWSWIRE
SparingVision appoints Joseph C. Papa as Chairman
05 Apr 2023 //
GLOBENEWSWIRE
SparingVision’s lead asset SPVN06 clears IND application in the US
01 Dec 2022 //
GLOBENEWSWIRE
SparingVision’s lead asset SPVN06 clears IND application in the US
01 Dec 2022 //
GLOBENEWSWIRE
SparingVision Raises €75 Million Series B to Continue Building World-Leading
14 Sep 2022 //
GLOBENEWSWIRE
Intellia expands ocular pipeline with 10% stake in SparingVision
14 Oct 2021 //
FIERCEBIOTECH
SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT
20 Apr 2021 //
GLOBENEWSWIRE
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as CEO
20 Oct 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.